
Thermo Fisher Scientific Inc: shareholders and insiders
Price
$686.79
November 17, 2026Market cap $255B
What Ploutos Investor adds for Thermo Fisher Scientific
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 27, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Glenview CapitalIn the quarter+150%
- Viking Global (Halvorsen)In the quarter+16%
- Duquesne (Druckenmiller)In the quarter
- Point72 (Cohen)In the quarter-21%
- D.E. ShawIn the quarter+112%
- Citadel Advisors (Griffin)In the quarter-33%
- Millennium Mgmt (Englander)In the quarter+134%
- AQR CapitalIn the quarter+105%
- Bridgewater (Dalio)In the quarter-11%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Glenview Capital | 627.2K | +150% | $315M | 6.28% |
| Viking Global (Halvorsen) | 1.94M | +16% | $971M | 2.77% |
| Duquesne (Druckenmiller) | 19.2K | $9.6M | 0.22% | |
| Point72 (Cohen) | 277.7K | -21% | $139M | 0.21% |
| D.E. Shaw | 641.6K | +112% | $322M | 0.20% |
| Citadel Advisors (Griffin) | 575.0K | -33% | $288M | 0.17% |
| Millennium Mgmt (Englander) | 165.5K | +134% | $83M | 0.06% |
| AQR Capital | 257.9K | +105% | $129M | 0.04% |
| Bridgewater (Dalio) | 12.9K | -11% | $6.5M | 0.03% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.32% of its shares outstanding were held short, -9.6% since the report before.
- Shares held short
- 4.89M
- 1.32%
- Since the report before5.41M on Sep 30, 2026
- -9.6%
- 2.2
- 2.28M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 26%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.75M
- Nov 15, 2023: Shares held short 2.72M
- Nov 30, 2023: Shares held short 2.50M
- Dec 15, 2023: Shares held short 2.91M
- Dec 29, 2023: Shares held short 2.93M
- Jan 12, 2024: Shares held short 2.92M
- Jan 31, 2024: Shares held short 2.88M
- Feb 15, 2024: Shares held short 2.91M
- Feb 29, 2024: Shares held short 2.94M
- Mar 15, 2024: Shares held short 3.43M
- Mar 28, 2024: Shares held short 2.58M
- Apr 15, 2024: Shares held short 2.59M
- Apr 30, 2024: Shares held short 2.77M
- May 15, 2024: Shares held short 2.80M
- May 31, 2024: Shares held short 3.24M
- Jun 14, 2024: Shares held short 3.19M
- Jun 28, 2024: Shares held short 3.39M
- Jul 15, 2024: Shares held short 3.04M
- Jul 31, 2024: Shares held short 3.58M
- Aug 15, 2024: Shares held short 3.32M
- Aug 30, 2024: Shares held short 3.54M
- Sep 13, 2024: Shares held short 3.99M
- Sep 30, 2024: Shares held short 3.45M
- Oct 15, 2024: Shares held short 3.05M
- Oct 31, 2024: Shares held short 2.93M
- Nov 15, 2024: Shares held short 3.23M
- Nov 29, 2024: Shares held short 3.54M
- Dec 13, 2024: Shares held short 3.96M
- Dec 31, 2024: Shares held short 3.52M
- Jan 15, 2025: Shares held short 3.46M
- Jan 31, 2025: Shares held short 3.95M
- Feb 14, 2025: Shares held short 3.86M
- Feb 28, 2025: Shares held short 4.15M
- Mar 14, 2025: Shares held short 4.27M
- Mar 31, 2025: Shares held short 3.94M
- Apr 15, 2025: Shares held short 4.79M
- Apr 30, 2025: Shares held short 4.54M
- May 15, 2025: Shares held short 4.57M
- May 30, 2025: Shares held short 4.74M
- Jun 13, 2025: Shares held short 4.91M
- Jun 30, 2025: Shares held short 4.41M
- Jul 15, 2025: Shares held short 3.83M
- Jul 31, 2025: Shares held short 3.71M
- Aug 15, 2025: Shares held short 3.82M
- Aug 29, 2025: Shares held short 3.94M
- Sep 15, 2025: Shares held short 3.83M
- Sep 30, 2025: Shares held short 4.27M
- Oct 15, 2025: Shares held short 3.91M
- Oct 31, 2025: Shares held short 4.41M
- Nov 14, 2025: Shares held short 5.46M
- Nov 28, 2025: Shares held short 5.10M
- Dec 15, 2025: Shares held short 5.09M
- Dec 31, 2025: Shares held short 3.90M
- Jan 15, 2026: Shares held short 3.89M
- Jan 30, 2026: Shares held short 4.77M
- Feb 13, 2026: Shares held short 3.56M
- Feb 27, 2026: Shares held short 3.55M
- Mar 13, 2026: Shares held short 3.88M
- Mar 31, 2026: Shares held short 4.07M
- Apr 15, 2026: Shares held short 4.54M
- Apr 30, 2026: Shares held short 4.87M
- May 15, 2026: Shares held short 4.77M
- May 29, 2026: Shares held short 4.69M
- Jun 15, 2026: Shares held short 4.42M
- Jun 30, 2026: Shares held short 5.35M
- Jul 15, 2026: Shares held short 5.30M
- Jul 31, 2026: Shares held short 4.99M
- Aug 14, 2026: Shares held short 4.74M
- Aug 31, 2026: Shares held short 5.69M
- Sep 15, 2026: Shares held short 5.02M
- Sep 30, 2026: Shares held short 5.41M
- Oct 15, 2026: Shares held short 4.89M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading42.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 42.0% of the shares in the reported trades were short sales, against 42.0% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 42.0%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 42.0%
- Change
- +0.0 pts
- Short sales a dayon average, of 789.8K shares
- 332.1K
- More than atof 3,666 US-listed companies, same days
- 25%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 36.9%
- Oct 12, 2026: Short sales 36.4%
- Oct 13, 2026: Short sales 28.8%
- Oct 14, 2026: Short sales 30%
- Oct 15, 2026: Short sales 45.7%
- Oct 16, 2026: Short sales 42.2%
- Oct 19, 2026: Short sales 41.1%
- Oct 20, 2026: Short sales 26.7%
- Oct 21, 2026: Short sales 47.7%
- Oct 22, 2026: Short sales 52%
- Oct 23, 2026: Short sales 43.9%
- Oct 26, 2026: Short sales 53.2%
- Oct 27, 2026: Short sales 53%
- Oct 28, 2026: Short sales 48.6%
- Oct 29, 2026: Short sales 39.7%
- Oct 30, 2026: Short sales 51%
- Nov 2, 2026: Short sales 53%
- Nov 3, 2026: Short sales 61.8%
- Nov 4, 2026: Short sales 29.8%
- Nov 5, 2026: Short sales 27.4%
- Nov 6, 2026: Short sales 36.2%
- Nov 9, 2026: Short sales 55%
- Nov 10, 2026: Short sales 55%
- Nov 11, 2026: Short sales 35.5%
- Nov 12, 2026: Short sales 48.3%
- Nov 13, 2026: Short sales 30.1%
- Nov 16, 2026: Short sales 33.9%
- Nov 17, 2026: Short sales 41.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Gianluca PettitiPresident and Chief Operating OfficerWhat happenedAdoptedJun 2, 2026Shares12.4K
- Marc N. CasperChairman and Chief Executive OfficerWhat happenedAdoptedApr 27, 2026Shares108.9K
- Michael D. ShaferExecutive Vice PresidentWhat happenedAdoptedDec 11, 2025Shares28.5K
- Stephen WilliamsonSenior Vice President and CFOWhat happenedAdoptedNov 30, 2025Shares6,000
- Marc N. CasperCEO, President and ChairmanWhat happenedAdoptedNov 11, 2025Shares137.5K
- Gianluca PettitiExecutive Vice PresidentWhat happenedAdoptedSep 12, 2025Shares4,175
- Frederick LoweryExecutive Vice PresidentWhat happenedAdoptedAug 28, 2025Shares13.8K
- Gianluca Pettitiexecutive vice presidentWhat happenedAdoptedFeb 10, 2025Shares–
- Michael A. Boxersenior vice president, general counselWhat happenedAdoptedDec 5, 2024Shares7,450
- Michael D. Shaferexecutive vice presidentWhat happenedAdoptedNov 20, 2024Shares–
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Gianluca PettitiPresident and Chief Operating Officer | AdoptedJun 2, 2026 | Mar 10, 2027 | 12.4K | 10-Q |
| Marc N. CasperChairman and Chief Executive Officer | AdoptedApr 27, 2026 | Jun 9, 2027 | 108.9K | 10-Q |
| Michael D. ShaferExecutive Vice President | AdoptedDec 11, 2025 | Dec 16, 2026 | 28.5K | 10-K |
| Stephen WilliamsonSenior Vice President and CFO | AdoptedNov 30, 2025 | Mar 4, 2026 | 6,000 | 10-K |
| Marc N. CasperCEO, President and Chairman | AdoptedNov 11, 2025 | Jun 9, 2027 | 137.5K | 10-K |
| Gianluca PettitiExecutive Vice President | AdoptedSep 12, 2025 | Jul 28, 2026 | 4,175 | 10-Q |
| Frederick LoweryExecutive Vice President | AdoptedAug 28, 2025 | Feb 27, 2026 | 13.8K | 10-Q |
| Gianluca Pettitiexecutive vice president | AdoptedFeb 10, 2025 | Dec 12, 2025 | – | 10-Q |
| Michael A. Boxersenior vice president, general counsel | AdoptedDec 5, 2024 | Jun 11, 2025 | 7,450 | 10-K |
| Michael D. Shaferexecutive vice president | AdoptedNov 20, 2024 | Dec 15, 2025 | – | 10-K |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$80M
Actually paid: $116M
$7.6M
Actually paid: $7.1M
$126
Peers: $157
Adjusted EPS
From the proxy statement (DEF 14A) of Apr 7, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Jun 27, 202610-QAmount$1,000M
- Mar 28, 202610-QAmount$3.0B
- Sep 27, 202510-QAmount$1,000M
- Mar 29, 202510-QAmount$2.0B
- Dec 31, 202410-KAmount$1.0B
- Mar 30, 202410-QAmount$3.0B
- Apr 1, 202310-QAmount$3.0B
- Dec 31, 202210-KAmount$1,000M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Jun 27, 202610-Q | 2.07M | $482.66 | $1,000M | $1.0B | 10-Q |
| Mar 28, 202610-Q | 4.87M | $616.04 | $3.0B | $2.0B | 10-Q |
| Sep 27, 202510-Q | 2.12M | $472.54 | $1,000M | $1.0B | 10-Q |
| Mar 29, 202510-Q | 3.64M | $549.58 | $2.0B | $1.0B | 10-Q |
| Dec 31, 202410-K | 1.89M | $529.49 | $1.0B | $3.0B | 10-K |
| Mar 30, 202410-Q | 5.52M | $543.17 | $3.0B | $1.0B | 10-Q |
| Apr 1, 202310-Q | 5.22M | $574.47 | $3.0B | $1.0B | 10-Q |
| Dec 31, 202210-K | 1.99M | $502.55 | $1,000M | $4.0B | 10-K |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 26, 2026For31.8%
- 2025May 28, 2025For35.6%
- 2024May 24, 2024For88.8%
- 2023May 26, 2023For79.0%
- 2022May 19, 2022For88.2%
- 2021May 20, 2021For83.0%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 26, 2026 | 31.8% | 99.93M | 215M | 1.27M | – | 8-K |
| 2025May 28, 2025 | 35.6% | 111M | 201M | 3.83M | 18.07M | 8-K |
| 2024May 24, 2024 | 88.8% | 281M | 35.31M | 3.01M | 18.94M | 8-K |
| 2023May 26, 2023 | 79.0% | 255M | 68.03M | 758.7K | 18.99M | 8-K |
| 2022May 19, 2022 | 88.2% | 286M | 38.25M | 1.07M | 18.39M | 8-K |
| 2021May 20, 2021 | 83.0% | 268M | 54.68M | 2.00M | 20.30M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- QLTYGMO U.S. Quality ETFWeight in the fund4.13%
- IYHiShares U.S. Healthcare ETFWeight in the fund3.52%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund3.24%
- VHTVanguard Health Care Index FundWeight in the fund3.18%
- PVALPutnam Focused Large Cap Value ETFWeight in the fund2.49%
- IXJiShares Global Healthcare ETFWeight in the fund2.42%
- MOATVanEck Morningstar Wide Moat ETFWeight in the fund1.18%
- MGVVanguard Morningstar Mega Cap Value Index FundWeight in the fund1.06%
- SCHGSchwab U.S. Large-Cap Growth ETFWeight in the fund0.88%
- CGGOCapital Group Global Growth Equity ETFWeight in the fund0.78%
54 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 2,517
- Q4 2025: Managers 2,707
- Q1 2026: Managers 2,614
- Q2 2026: Managers 2,620
Institutional investors by quarter
The fund managers holding TMO, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 2,620 managers held 336M shares, worth $169B. During the quarter 199 opened a position, 193 closed one, 914 added and 1,145 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+1.6%
- Vanguard Capital ManagementIn the quarter
- State StreetIn the quarter+0.6%
- FMRIn the quarter+31%
- Morgan StanleyIn the quarter-0.9%
- JPMorgan ChaseIn the quarter+25%
- Geode Capital ManagementIn the quarter-0.3%
- Franklin ResourcesIn the quarter+6.7%
- Vanguard Portfolio ManagementIn the quarter+1.0%
- Capital World InvestorsIn the quarter-6.8%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 30.92M | +1.6% | $15.5B |
| Vanguard Capital Management | 24.28M | $12.2B | |
| State Street | 16.83M | +0.6% | $8.4B |
| FMR | 14.08M | +31% | $7.1B |
| Morgan Stanley | 10.76M | -0.9% | $5.4B |
| JPMorgan Chase | 8.50M | +25% | $4.3B |
| Geode Capital Management | 8.38M | -0.3% | $4.2B |
| Franklin Resources | 7.27M | +6.7% | $3.6B |
| Vanguard Portfolio Management | 6.23M | +1.0% | $3.1B |
| Capital World Investors | 6.20M | -6.8% | $3.1B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Thermo Fisher Scientific's filings show?
Who buys and sells is one part of Thermo Fisher Scientific's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold TMO?
9 of the managers we track held the shares on Jun 30, 2026. The largest position was Viking Global (Halvorsen)'s, worth $971M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.